The DiaGene: a prospective case-control study Sunny Singh Badal MD, - - PowerPoint PPT Presentation

the diagene a prospective case control study
SMART_READER_LITE
LIVE PREVIEW

The DiaGene: a prospective case-control study Sunny Singh Badal MD, - - PowerPoint PPT Presentation

The DiaGene: a prospective case-control study Sunny Singh Badal MD, PHD student Department: Vascular Medicine Type 2 Diabetes Mellitus (T2DM) RIVM: Rising prevalence and incidence Prevalence 2017: 1135100 Incidence 2017:


slide-1
SLIDE 1

The DiaGene: a prospective case-control study

Sunny Singh Badal MD, PHD student Department: Vascular Medicine

slide-2
SLIDE 2

Type 2 Diabetes Mellitus (T2DM)

  • RIVM: Rising prevalence and incidence
  • Prevalence 2017: 1135100
  • Incidence 2017: 60200
  • Still high percentage develop complications
slide-3
SLIDE 3

Methods

  • DiaGene study
  • Multicenter prospective case-control study
  • DM2 cases, healthy controls
  • Eindhoven: Maxima Medisch Centrum,

Catharina Hospital, Diagnostic Center Eindhoven (General practioners)

Van Herpt, Thijs T. W. et al. “Introduction of the DiaGene Study: Clinical Characteristics, Pathophysiology and Determinants of Vascular Complications of Type 2 Diabetes.” Diabetology & Metabolic Syndrome 9 (2017): 47. PMC. Web. 16 July 2017

slide-4
SLIDE 4

Methods

DM, diabetes mellitus; MODY, Maturity-Onset Diabetes of the Young; Latent Auto-immune Diabetes of the Adult

slide-5
SLIDE 5

Statistics

Endpoints

Macrovascular complications: Ischemic brain disease, ischemic heart disease. PAD etc. Microvascular complications

  • Retinopathy, nephropathy, neuropathy, composite endpoint

Genetic associations with incident and prevalent complications will be assessed